News
VINC
0.2305
-2.04%
-0.0048
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 2d ago
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 12/30/2024 21:05
Weekly Report: what happened at VINC last week (1223-1227)?
Weekly Report · 12/30/2024 11:23
Why Vincerx Pharma Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket
Benzinga · 12/30/2024 09:56
VINC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Vincerx Pharma, Inc. Is Fair to Shareholders
Barchart · 12/30/2024 09:17
Shareholder Alert: Ademi LLP Investigates Whether Vincerx Pharma, Inc. Is Obtaining a Fair Price for Its Public Shareholders
Barchart · 12/30/2024 08:30
Vincerx Pharma Stock Rises On Proposed Merger With Oqory: Retail Remains Bullish
Barchart · 12/30/2024 00:14
Vincerx Pharma To Merge With Oqory; Cuts Jobs
NASDAQ · 12/28/2024 02:46
VINCERX PHARMA INC: FILES FOR OFFERING OF 2.8 MLN COMMON STOCK - SEC FILING
Reuters · 12/27/2024 21:32
Vincerx Pharma Announces Merger, Leadership Changes, and Financing
TipRanks · 12/27/2024 21:31
Vincerx Pharma Inc trading resumes
TipRanks · 12/27/2024 21:30
Vincerx Pharma To Be Acquired by Private Biotech, Cut Headcount
Dow Jones · 12/27/2024 21:28
Vincerx Pharma enters binding term sheet for merger with Oqory
TipRanks · 12/27/2024 21:10
*Vincerx Pharma: Kevin Hass, the Company's Vice Pres and Controller, Has Taken Over as Acting Chief Fincl Officer >VINC
Dow Jones · 12/27/2024 21:07
*Vincerx Pharma: Raquel Izumi Has Stepped Dn as Pres and Chief Ops Officer and Taken Over as Acting CEO in a Consulting Capacity >VINC
Dow Jones · 12/27/2024 21:07
*Vincerx Pharma: Alexander Seelenberger Has Stepped Dn as Chief Fincl Officer >VINC
Dow Jones · 12/27/2024 21:07
*Vincerx Pharma: Implementing Additional Streamlining and Cost-Control Measures, Including a Workforce Reduction >VINC
Dow Jones · 12/27/2024 21:06
*Vincerx Pharma: Ahmed Hamdy, Chmn and CEO, Stepped Dn as CEO but Will Remain as Chmn >VINC
Dow Jones · 12/27/2024 21:06
Vincerx Pharma Inc trading halted, news pending
TipRanks · 12/27/2024 21:05
VINCERX PHARMA INC: AHMED HAMDY, CHAIRMAN AND CEO HAS STEPPED DOWN AS CEO BUT WILL REMAIN AS CHAIRMAN
Reuters · 12/27/2024 21:05
More
Webull provides a variety of real-time VINC stock news. You can receive the latest news about Vincerx Pharma Inc through multiple platforms. This information may help you make smarter investment decisions.
About VINC
Vincerx Pharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing differentiated and novel therapies to address the unmet medical needs of patients with cancer. It has a next generation bioconjugation platform, called VersAptx. The VersAptx platform is a versatile and adaptable, next generation bioconjugation platform. Its product candidates include VIP943 (CD123-KSPi), VIP924 (CXCR5-KSPi), VIP236, and Enitociclib (P-TEFb/CDK9 inhibitor). VIP943 is a potential anti-CD123 ADC created with its VersAptx Platform. It consists of an anti-CD123 antibody, a novel legumain-cleavable linker, and a KSPi payload enhanced with its CellTrapper technology. Enitociclib is a selective CDK9 inhibitor. Enitociclib effectively blocks P-TEFb-mediated activation of RNA polymerase II, preventing transcription of MCL1 and MYC, proteins associated with poor prognosis in various types of cancer.